India to Thailand: Paclitaxel Export Trade Route
India has recorded 135 verified shipments of Paclitaxel exported to Thailand, representing a combined trade value of $4.7M USD. This corridor is served by 12 active Indian exporters, with an average shipment value of $34.5K USD. The leading Indian exporter is FRESENIUS KABI ONCOLOGY LIMITED, which accounts for 46% of total export value with 30 shipments worth $2.2M USD. On the buying side, FRESENIUS KABI THAILAND LTD is the largest importer in Thailand with $703.6K USD in purchases. The top 3 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, KARDI TRADING PRIVATE LIMITED, FRESENIUS KABI ONCOLOGY LIMITED — together control 89% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Thailand Paclitaxel corridor is one of India's established pharmaceutical export routes, with 135 shipments documented worth a combined $4.7M USD. The route is dominated by FRESENIUS KABI ONCOLOGY LIMITED, which alone accounts for roughly 46% of all export value, reflecting the consolidated nature of India's paclitaxel manufacturing sector.
Across 12 active suppliers, the average shipment value stands at $34.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 15.7%, placing it at rank #4 among India's top paclitaxel export destinations globally.
On the import side, key buyers of Indian paclitaxel in Thailand include FRESENIUS KABI THAILAND LTD, FRESENIUS KABI (THAILAND) LTD.,, FRESENIUS KABI (THAILAND) LTD and 30 others. FRESENIUS KABI THAILAND LTD is the single largest importer with 6 shipments valued at $703.6K USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portDELHI AIR
Market Position
- Global rank#4
- Annual growth+15.7%
- Demand growth+13.7%
- Regulatory ease70/100
Top 10 Indian Paclitaxel Exporters to Thailand
Showing top 10 of 12 Indian suppliers exporting Paclitaxel to Thailand, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI ONCOLOGY LIMITED Avg $71.8K per shipment | 30 | $2.2M | 46.2% |
| 2 | KARDI TRADING PRIVATE LIMITED Avg $31.5K per shipment | 36 | $1.1M | 24.3% |
| 3 | FRESENIUS KABI ONCOLOGY LIMITED Avg $78.1K per shipment | 11 | $859.5K | 18.4% |
| 4 | VENUS REMEDIES LIMITED Avg $16.5K per shipment | 18 | $297.2K | 6.4% |
| 5 | VENUS REMEDIES LIMITED Avg $10.2K per shipment | 11 | $112.4K | 2.4% |
| 6 | KARDI TRADING PRIVATE LIMITED Avg $55.5K per shipment | 1 | $55.5K | 1.2% |
| 7 | GLS PHARMA LIMITED Avg $4.7K per shipment | 9 | $42.1K | 0.9% |
| 8 | MBA PHARMACEUTICALS PRIVATE LIMITED Avg $680 per shipment | 5 | $3.4K | 0.1% |
| 9 | PROSPERA LIFE SCIENCES PRIVATE LIMITED Avg $457 per shipment | 4 | $1.8K | 0.0% |
| 10 | VIOTONIC MEDICATION Avg $886 per shipment | 2 | $1.8K | 0.0% |
This table shows the top 10 of 12 Indian companies exporting paclitaxel to Thailand, ranked by total trade value. The listed exporters are: FRESENIUS KABI ONCOLOGY LIMITED, KARDI TRADING PRIVATE LIMITED, FRESENIUS KABI ONCOLOGY LIMITED , VENUS REMEDIES LIMITED, VENUS REMEDIES LIMITED , KARDI TRADING PRIVATE LIMITED , GLS PHARMA LIMITED, MBA PHARMACEUTICALS PRIVATE LIMITED, PROSPERA LIFE SCIENCES PRIVATE LIMITED , VIOTONIC MEDICATION. FRESENIUS KABI ONCOLOGY LIMITED is the dominant supplier with 30 shipments worth $2.2M USD, giving it a 46% market share. The top 3 suppliers together account for 89% of the total trade value on this route.
Showing top 10 of 12 total Indian exporters on the India to Thailand Paclitaxel export route.
Top 10 Paclitaxel Importers in Thailand
Showing top 10 of 33 known buyers in Thailand receiving Paclitaxel shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian paclitaxel in Thailand include FRESENIUS KABI THAILAND LTD, FRESENIUS KABI (THAILAND) LTD.,, FRESENIUS KABI (THAILAND) LTD, STR INTERNATIONAL TRADING CO LIMITED PHUM TOUL, TO THE ORDER OF, among 33 total buyers. The largest importer is FRESENIUS KABI THAILAND LTD, accounting for $703.6K USD across 6 shipments — representing 15% of all paclitaxel imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | FRESENIUS KABI THAILAND LTD | 6 | $703.6K | 15.1% |
| 2 | FRESENIUS KABI (THAILAND) LTD., | 5 | $573.1K | 12.3% |
| 3 | FRESENIUS KABI (THAILAND) LTD | 10 | $433.7K | 9.3% |
| 4 | STR INTERNATIONAL TRADING CO LIMITED PHUM TOUL | 10 | $366.0K | 7.9% |
| 5 | TO THE ORDER OF | 8 | $308.0K | 6.6% |
| 6 | FRESENIUS KABI (THAILAND) LTD | 5 | $228.4K | 4.9% |
| 7 | FRESENIUS KABI(THAILAND)LIMITED | 3 | $225.0K | 4.8% |
| 8 | FRESENIUS KABI(THAILAND)LTD | 3 | $221.9K | 4.8% |
| 9 | FRESENIUS KABI (THAILAND) LTD., | 1 | $204.8K | 4.4% |
| 10 | FRESENIUS KABI (THAILAND) LTD. | 2 | $204.5K | 4.4% |
Showing top 10 of 33 Paclitaxel importers in Thailand on this route.
Top 10 Paclitaxel Formulations Imported by Thailand
Showing top 10 of 111 product formulations shipped on the India to Thailand Paclitaxel route, ranked by trade value
Thailand imports a wide range of paclitaxel formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — INTAXEL (PACLITAXEL) USP INJ. 300MG/50ML — accounts for $465.8K USD across 3 shipments. There are 111 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAXEL (PACLITAXEL) USP INJ. 300MG/50ML | 3 | $465.8K | 10.0% |
| 2 | INTAXEL PACLITAXEL USP INJ 300MG 50MLVIAL BATCH NO 87230064AA MFG DT 02 2023 EXP DT 01 2025 | 2 | $296.6K | 6.4% |
| 3 | INTAXEL PACLITAXEL USP INJ 300MG 50MLVIAL BATCH NO 87250133AA 87250132AA MFG 04 2025 EXP 03 2027 16787 VIALS | 1 | $249.0K | 5.3% |
| 4 | INTAXEL (PACLITAXEL) USP INJ. 300MG/50MLVIAL BT NO.87240506AA & 87240507AC MFG.12/2024,EXP.11/2026 (16741 VIALS) | 1 | $226.9K | 4.9% |
| 5 | PALIT SPAL 100MG (PACLITAXEL PROTEIN | 5 | $195.7K | 4.2% |
| 6 | INTAXEL (PACLITAXEL)USP INJ.300MG/50ML V | 1 | $179.4K | 3.8% |
| 7 | INTAXEL(PACLITAXEL)USP INJ.300MG/50ML | 1 | $156.9K | 3.4% |
| 8 | INTAXEL (PACLITAXEL) USP INJ. 300MG/50MLVIAL BNO.87230526AA, MFG. DT. 12/2023,EXP. DT. 11/2025NOS | 1 | $146.5K | 3.1% |
| 9 | INTAXEL(PACLITAXEL)INJ.300MG/50ML VIALB NO-87240173AAMFG.DT.05/24 EXP.DT. 04/2026 | 1 | $143.7K | 3.1% |
| 10 | INTAXEL PACLITAXEL USP INJ. 300MG/50ML | 1 | $132.8K | 2.8% |
Showing top 10 of 111 Paclitaxel formulations imported by Thailand on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
DELHI AIR handles the highest volume with 36 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's paclitaxel exports to Thailand are driven primarily by a handful of large-scale manufacturers. FRESENIUS KABI ONCOLOGY LIMITED with 30 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 12 active exporters signals a competitive but concentrated market — buyers in Thailand benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, KARDI TRADING PRIVATE LIMITED, FRESENIUS KABI ONCOLOGY LIMITED — together account for 89% of total trade value on this route. The average shipment value of $34.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as intaxel paclitaxel usp inj 300mg 50mlvial batch no 87230064aa mfg dt 02 2023 exp dt 01 2025 and intaxel paclitaxel usp inj 300mg 50mlvial batch no 87250133aa 87250132aa mfg 04 2025 exp 03 2027 16787 vials, suggesting that buyers in Thailand tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, FRESENIUS KABI THAILAND LTD is the largest importer with 6 shipments worth $703.6K USD — representing 15% of all paclitaxel imports from India on this route. A total of 33 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $4.7M
- Avg. Shipment
- $34.5K
- Suppliers
- 12
- Buyers
- 33
- Transit (Sea)
- ~24 days
- Annual Growth
- +15.7%
Related Analysis
Reverse Direction
Thailand → India — Paclitaxel (Import)Other Paclitaxel Routes
Unlock the Full India to Thailand Paclitaxel Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 135 shipments on this route.
Frequently Asked Questions — India to Thailand Paclitaxel Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Paclitaxel to Thailand?
The leading Indian exporters of Paclitaxel to Thailand are FRESENIUS KABI ONCOLOGY LIMITED, KARDI TRADING PRIVATE LIMITED, FRESENIUS KABI ONCOLOGY LIMITED . FRESENIUS KABI ONCOLOGY LIMITED holds the largest market share at approximately 46% of total trade value on this route.
Q What is the total value of Paclitaxel exports from India to Thailand?
India exports Paclitaxel to Thailand worth approximately $4.7M USD across 135 recorded shipments. The average value per shipment is $34.5K USD.
Q Which ports does India use to ship Paclitaxel to Thailand?
The most active port of origin is DELHI AIR with 36 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Thailand for Paclitaxel?
The average transit time for Paclitaxel shipments from India to Thailand is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Thailand Paclitaxel trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 15.7% with demand growth tracking at 13.7%. The route is ranked #4 among India's top Paclitaxel export destinations globally.
Q How many suppliers are active on the India to Thailand Paclitaxel route?
There are currently 12 active Indian suppliers exporting Paclitaxel to Thailand. The market is moderately concentrated with FRESENIUS KABI ONCOLOGY LIMITED accounting for 46% of total shipment value.
Q Who are the main importers of Paclitaxel from India in Thailand?
The leading importers of Indian Paclitaxel in Thailand include FRESENIUS KABI THAILAND LTD, FRESENIUS KABI (THAILAND) LTD.,, FRESENIUS KABI (THAILAND) LTD, STR INTERNATIONAL TRADING CO LIMITED PHUM TOUL, TO THE ORDER OF. FRESENIUS KABI THAILAND LTD is the largest buyer with 6 shipments worth $703.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Thailand export trade corridor identified from Indian Customs (DGFT) records for Paclitaxel.
- 2.Supplier/Buyer Matching: 12 Indian exporters and 33 importers in Thailand matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 135 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
135 Verified Shipments
12 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists